US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Jazz Pharmaceuticals PLC

180.62

-1.1800-0.65%

Post-market: 180.620.00000.00%19:27 EDT

Volume:1.08M

Turnover:194.81M

Market Cap:11.12B

PE:-30.93

High:184.00

Open:181.93

Low:179.16

Close:181.80

52wk High:198.00

52wk Low:95.49

Shares:61.56M

Float Shares:58.65M

Volume Ratio:1.54

T/O Rate:1.84%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-5.8403

EPS(LYR):-5.8403

ROE:-8.47%

ROA:5.22%

PB:2.57

PE(LYR):-30.93

Loading ...

Overview Company News Filings

Press Release: Jazz Pharmaceuticals Appoints Thomas Riga as Chief Business Officer

RBC Trims Price Target on Jazz Pharmaceuticals to $191 From $194, Keeps Outperform Rating

MT Newswires Live

Jazz Pharmaceuticals' Drug Extends Survival Past Two Years in Advanced Stomach Cancer Trial

Benzinga_recent_news

Jazz Pharmaceuticals Reports Phase 3 Success for Ziihera in First-Line HER2+ Metastatic GEA

Ziihera® (Zanidatamab-Hrii) Combinations Achieve Unprecedented Results in First-Line Her2+ Locally Advanced or Metastatic Gea Including More Than Two Years Median Overall Survival Benefit

THOMSON REUTERS

Jazz Pharmaceuticals Plc: Additional Planned Os Interim Analysis for Ziihera Plus Chemotherapy Is Currently Expected in Mid-2026

THOMSON REUTERS

Jazz Pharmaceuticals to Present Phase 3 Zanidatamab Trial Results at Investor Webcast

Jazz Pharmaceuticals (JAZZ): Valuation Check After Positive Ziihera and Epidiolex Clinical Updates Boost Investor Interest

Simply Wall St.

Jazz Pharmaceuticals SVP Technical Operations Mary Elizabeth Henderson Reports Sale of Common Shares

Jazz Pharmaceuticals Price Target Raised to $219.00/Share From $147.00 by Piper Sandler

Jazz Pharmaceuticals SVP Chief Accounting Officer Patricia Carr Reports Disposal of Common Shares

Jazz Pharmaceuticals Highlights New Epidiolex Data in Treatment-Resistant Epilepsies at AES 2025

Jazz Pharmaceuticals Announces Positive Phase 3 Results for Ziihera in HER2-Positive Gastroesophageal Cancer

Saniona AB Q3 2025 revenue surged to SEK 410.7 million, nearly 57 times higher

Director Heather Ann McSharry Reports Disposal of Jazz Pharmaceuticals plc Common Shares

Jazz Gains From Ziihera Data, Upside Seen as Priced In, UBS Says

MT Newswires Live

Jazz Pharmaceuticals Cut to Neutral From Buy by UBS

Jazz Pharmaceuticals downgraded to Neutral from Buy at UBS

Jazz Pharmaceuticals Plc : UBS Cuts to Neutral From Buy; Raises Target Price to $188 From $163

THOMSON REUTERS

A Look at Jazz Pharmaceuticals's Valuation After Landmark HERIZON-GEA-01 Ziihera Trial Results

Simply Wall St.

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/JAZZ/news?page=4"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"JAZZ","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"JAZZ\",,,,,undefined,":{"symbol":"JAZZ","market":"US","secType":"STK","nameCN":"Jazz Pharmaceuticals PLC","latestPrice":180.62,"timestamp":1774036800000,"preClose":181.8,"halted":0,"volume":1076791,"hourTrading":{"tag":"盘后","latestPrice":180.62,"preClose":180.62,"latestTime":"19:27 EDT","volume":176846,"amount":31941879.83462,"timestamp":1774049277408,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":-0.0064906490649065274,"floatShares":58654338,"shares":61560350,"eps":-5.84031,"marketStatus":"Market Closed","change":-1.18,"latestTime":"03-20 16:00:00 EDT","open":181.93,"high":184,"low":179.1575,"amount":194808397.51869997,"amplitude":0.026636,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-5.84031,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1774252800000},"marketStatusCode":7,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":181.8,"preHourTrading":{"tag":"盘前","latestPrice":178.75,"preClose":181.8,"latestTime":"09:25 EDT","volume":67,"amount":12183.150020000001,"timestamp":1774013100061,"change":-3.05,"changeRate":-0.016777,"amplitude":0.017327},"postHourTrading":{"tag":"盘后","latestPrice":180.62,"preClose":180.62,"latestTime":"19:27 EDT","volume":176846,"amount":31941879.83462,"timestamp":1774049277408,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":1.539220971499776,"impliedVol":0.3252,"impliedVolPercentile":0.2191},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"JAZZ\",,,,,undefined,":{"symbol":"JAZZ","floatShares":58654338,"roa":"5.22%","roe":"-8.47%","lyrEps":-5.84031,"volumeRatio":1.539220971499776,"shares":61560350,"dividePrice":0,"high":184,"amplitude":0.026636,"preClose":181.8,"low":179.1575,"week52Low":95.49,"pbRate":"2.57","psRate":"2.61","week52High":198,"institutionHeld":0,"latestPrice":180.62,"eps":-5.84031,"divideRate":0,"volume":1076791,"delay":0,"ttmEps":-5.84031,"open":181.93,"prevYearClose":170,"prevWeekClose":178.55,"prevMonthClose":190.02,"prevQuarterClose":170,"fiveDayClose":178.55,"twentyDayClose":172.19,"sixtyDayClose":169.67},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/JAZZ\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-02-24","symbol":"JAZZ","fiscalQuarterEnding":"2025/12","expectedEps":5.65,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1771909200000,"reportTimeType":"post","actualEps":5.76},{"market":"US","date":"2025-11-05","symbol":"JAZZ","fiscalQuarterEnding":"2025/09","expectedEps":4.8,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1762318800000,"reportTimeType":"post","actualEps":6.99},{"market":"US","date":"2025-08-05","symbol":"JAZZ","fiscalQuarterEnding":"2025/06","expectedEps":-6.47,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1754366400000,"reportTimeType":"post","actualEps":-9.07},{"market":"US","date":"2025-05-06","symbol":"JAZZ","fiscalQuarterEnding":"2025/03","expectedEps":3.96,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1746504000000,"reportTimeType":"post","actualEps":0.6},{"market":"US","date":"2025-02-25","symbol":"JAZZ","fiscalQuarterEnding":"2024/12","expectedEps":4.98,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1740459600000,"reportTimeType":"post","actualEps":5.7}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"JAZZ\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"JAZZ\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.3529,"buy":0.5882,"hold":0.0588,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.5882,"analysts":17,"updateTime":1772251200000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/JAZZ\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"JAZZ","date":"2026-03-20","current":-30.926441,"percent":0.32708,"low":-540.707731,"twenty":-53.279321,"median":-19.653443,"eighty":20.433288,"high":261.103916,"avg":-34.620553,"sd":144.451582,"marketCap":11191671630},"quantilePoints":[{"date":"2021-03-26","current":39.755632,"twenty":15.544862,"median":22.890616,"eighty":37.794835,"marketCap":9486329931},{"date":"2021-04-01","current":38.995549,"twenty":15.544862,"median":22.890616,"eighty":37.794835,"marketCap":9304962027},{"date":"2021-04-09","current":38.098557,"twenty":15.539951,"median":22.886589,"eighty":37.680039,"marketCap":9090925370},{"date":"2021-04-16","current":39.868936,"twenty":15.539951,"median":22.886589,"eighty":37.680039,"marketCap":9513366140},{"date":"2021-04-23","current":39.356707,"twenty":15.539951,"median":22.886589,"eighty":37.680039,"marketCap":9391139944},{"date":"2021-04-30","current":38.806709,"twenty":15.539951,"median":22.886589,"eighty":37.680039,"marketCap":9259901678},{"date":"2021-05-07","current":20.445615,"twenty":15.539951,"median":22.828577,"eighty":34.921298,"marketCap":10596574014},{"date":"2021-05-14","current":20.981963,"twenty":15.539951,"median":22.792403,"eighty":31.049676,"marketCap":10874552759},{"date":"2021-05-21","current":21.079161,"twenty":15.539951,"median":22.729021,"eighty":30.708575,"marketCap":10924928820},{"date":"2021-05-28","current":20.860172,"twenty":15.539951,"median":22.690051,"eighty":29.251849,"marketCap":10811430948},{"date":"2021-06-04","current":20.326167,"twenty":15.539951,"median":22.66338,"eighty":29.066489,"marketCap":10534666084},{"date":"2021-06-11","current":21.902652,"twenty":15.539951,"median":22.570359,"eighty":28.938372,"marketCap":11351728409},{"date":"2021-06-18","current":20.856755,"twenty":15.539951,"median":22.546699,"eighty":28.823366,"marketCap":10809660055},{"date":"2021-06-25","current":21.30382,"twenty":15.539951,"median":22.529137,"eighty":28.697412,"marketCap":11041365313},{"date":"2021-07-02","current":21.353233,"twenty":15.539951,"median":22.480863,"eighty":28.609672,"marketCap":11066974842},{"date":"2021-07-09","current":21.646178,"twenty":15.539951,"median":22.461902,"eighty":28.493579,"marketCap":11218802761},{"date":"2021-07-16","current":20.636752,"twenty":15.539951,"median":22.408914,"eighty":28.160581,"marketCap":10695636677},{"date":"2021-07-23","current":20.462632,"twenty":15.539951,"median":22.362439,"eighty":28.079318,"marketCap":10605393577},{"date":"2021-07-30","current":19.943802,"twenty":15.539951,"median":22.307175,"eighty":27.989103,"marketCap":10336493527},{"date":"2021-08-06","current":228.431671,"twenty":15.539951,"median":22.306554,"eighty":27.980122,"marketCap":9174729642},{"date":"2021-08-13","current":216.434593,"twenty":15.539951,"median":22.306554,"eighty":27.980122,"marketCap":8692879005},{"date":"2021-08-20","current":203.271885,"twenty":15.539951,"median":22.306554,"eighty":27.980122,"marketCap":8164211991},{"date":"2021-08-27","current":202.738962,"twenty":15.539951,"median":22.306554,"eighty":27.980122,"marketCap":8142807689},{"date":"2021-09-03","current":208.494526,"twenty":15.539951,"median":22.306554,"eighty":27.989103,"marketCap":8373974141},{"date":"2021-09-10","current":204.962011,"twenty":15.539951,"median":22.306554,"eighty":28.079318,"marketCap":8232094203},{"date":"2021-09-17","current":202.845547,"twenty":15.539951,"median":22.306554,"eighty":28.15225,"marketCap":8147088550},{"date":"2021-09-24","current":206.088761,"twenty":15.539951,"median":22.306554,"eighty":28.15225,"marketCap":8277349011},{"date":"2021-10-01","current":197.896981,"twenty":15.539951,"median":22.306554,"eighty":28.336851,"marketCap":7948334325},{"date":"2021-10-08","current":207.032796,"twenty":15.539951,"median":22.306554,"eighty":28.514954,"marketCap":8315265201},{"date":"2021-10-15","current":214.234863,"twenty":15.539951,"median":22.306554,"eighty":28.855634,"marketCap":8604529042},{"date":"2021-10-22","current":220.538575,"twenty":15.539951,"median":22.306554,"eighty":28.974281,"marketCap":8857711346},{"date":"2021-10-29","current":202.571473,"twenty":15.539951,"median":22.306554,"eighty":29.465696,"marketCap":8136080623},{"date":"2021-11-05","current":205.647197,"twenty":15.539951,"median":22.307175,"eighty":38.033407,"marketCap":8259614018},{"date":"2021-11-12","current":-53.304535,"twenty":15.334919,"median":22.307175,"eighty":38.099501,"marketCap":8576859566},{"date":"2021-11-19","current":-49.041089,"twenty":15.19186,"median":22.307175,"eighty":38.099501,"marketCap":7890858328},{"date":"2021-11-26","current":-47.406004,"twenty":15.149879,"median":22.307175,"eighty":38.099501,"marketCap":7627768248},{"date":"2021-12-03","current":-45.942832,"twenty":14.992993,"median":22.307175,"eighty":38.099501,"marketCap":7392339507},{"date":"2021-12-10","current":-46.882624,"twenty":14.940831,"median":22.307175,"eighty":38.099501,"marketCap":7543554834},{"date":"2021-12-17","current":-47.864439,"twenty":14.904858,"median":22.307175,"eighty":38.099501,"marketCap":7701531822},{"date":"2021-12-23","current":-48.972324,"twenty":14.853801,"median":22.307175,"eighty":38.099501,"marketCap":7879793792},{"date":"2021-12-31","current":-48.670521,"twenty":14.753542,"median":22.307175,"eighty":38.099501,"marketCap":7831232773},{"date":"2022-01-07","current":-51.356186,"twenty":14.626899,"median":22.306864,"eighty":38.099029,"marketCap":8263364377},{"date":"2022-01-14","current":-55.126814,"twenty":14.584124,"median":22.306864,"eighty":38.099029,"marketCap":8870069773},{"date":"2022-01-21","current":-52.246314,"twenty":14.51891,"median":22.291453,"eighty":38.099029,"marketCap":8406588650},{"date":"2022-01-28","current":-52.032378,"twenty":14.422364,"median":22.291453,"eighty":38.099029,"marketCap":8372165649},{"date":"2022-02-04","current":-53.843196,"twenty":14.223531,"median":22.27218,"eighty":38.099029,"marketCap":8663531766},{"date":"2022-02-11","current":-54.229045,"twenty":14.132265,"median":22.189917,"eighty":38.099029,"marketCap":8725616107},{"date":"2022-02-18","current":-52.678007,"twenty":14.040482,"median":22.12737,"eighty":38.099029,"marketCap":8476049349},{"date":"2022-02-25","current":-53.178465,"twenty":13.972466,"median":22.109742,"eighty":38.099029,"marketCap":8556574584},{"date":"2022-03-04","current":-28.91913,"twenty":13.940317,"median":22.080345,"eighty":38.099029,"marketCap":9533711827},{"date":"2022-03-11","current":-28.967822,"twenty":13.867469,"median":22.040876,"eighty":38.099029,"marketCap":9549763925},{"date":"2022-03-18","current":-29.329264,"twenty":13.783843,"median":21.968511,"eighty":38.099029,"marketCap":9668919889},{"date":"2022-03-25","current":-30.095222,"twenty":13.705849,"median":21.933463,"eighty":38.099029,"marketCap":9921431748},{"date":"2022-04-01","current":-29.758126,"twenty":13.589272,"median":21.860937,"eighty":38.099029,"marketCap":9810301834},{"date":"2022-04-08","current":-31.031601,"twenty":13.549318,"median":21.794989,"eighty":38.099029,"marketCap":10230125953},{"date":"2022-04-14","current":-31.321879,"twenty":13.450679,"median":21.754606,"eighty":38.099029,"marketCap":10325821157},{"date":"2022-04-22","current":-30.525957,"twenty":13.411427,"median":21.659472,"eighty":38.099029,"marketCap":10063431083},{"date":"2022-04-29","current":-30.00533,"twenty":13.314049,"median":21.637622,"eighty":38.099029,"marketCap":9891797105},{"date":"2022-05-06","current":-21.145426,"twenty":13.178574,"median":21.610502,"eighty":38.099029,"marketCap":9512333236},{"date":"2022-05-13","current":-20.293458,"twenty":12.881793,"median":21.573299,"eighty":38.099029,"marketCap":9129072955},{"date":"2022-05-20","current":-20.576062,"twenty":12.577766,"median":21.475486,"eighty":38.099029,"marketCap":9256203194},{"date":"2022-05-27","current":-20.905767,"twenty":12.351439,"median":21.387948,"eighty":38.099029,"marketCap":9404521807},{"date":"2022-06-03","current":-21.011331,"twenty":12.181055,"median":21.327652,"eighty":38.099029,"marketCap":9452010395},{"date":"2022-06-10","current":-20.433648,"twenty":12.084535,"median":21.299229,"eighty":38.099029,"marketCap":9192137755},{"date":"2022-06-17","current":-19.836846,"twenty":11.871718,"median":21.132824,"eighty":38.099029,"marketCap":8923664534},{"date":"2022-06-24","current":-21.305419,"twenty":11.825322,"median":20.994404,"eighty":38.099501,"marketCap":9584306692},{"date":"2022-07-01","current":-22.011944,"twenty":11.79083,"median":20.915212,"eighty":38.099501,"marketCap":9902139261},{"date":"2022-07-08","current":-21.973079,"twenty":11.712989,"median":20.863685,"eighty":38.099501,"marketCap":9884655348},{"date":"2022-07-15","current":-21.853705,"twenty":11.637295,"median":20.849696,"eighty":38.099501,"marketCap":9830954757},{"date":"2022-07-22","current":-21.866198,"twenty":11.538484,"median":20.810988,"eighty":38.099501,"marketCap":9836574586},{"date":"2022-07-29","current":-21.662152,"twenty":11.434468,"median":20.636752,"eighty":38.099501,"marketCap":9744784040},{"date":"2022-08-05","current":-185.751135,"twenty":11.344316,"median":20.569748,"eighty":38.099501,"marketCap":9635282891},{"date":"2022-08-12","current":-189.811269,"twenty":11.27714,"median":20.449691,"eighty":38.099501,"marketCap":9845890167},{"date":"2022-08-19","current":-189.291669,"twenty":11.157183,"median":20.353101,"eighty":38.099501,"marketCap":9818937451},{"date":"2022-08-26","current":-188.349138,"twenty":11.095545,"median":20.083804,"eighty":38.099501,"marketCap":9770046476},{"date":"2022-09-02","current":-187.152848,"twenty":11.013431,"median":19.45687,"eighty":38.099501,"marketCap":9707992546},{"date":"2022-09-09","current":-184.47026,"twenty":10.96191,"median":19.265635,"eighty":38.099501,"marketCap":9568841310},{"date":"2022-09-16","current":-178.22297,"twenty":10.924789,"median":19.105809,"eighty":38.099501,"marketCap":9244781900},{"date":"2022-09-23","current":-154.273012,"twenty":10.856762,"median":18.986588,"eighty":38.099501,"marketCap":8002449692},{"date":"2022-09-30","current":-161.06407,"twenty":10.792014,"median":18.878263,"eighty":38.099501,"marketCap":8354715434},{"date":"2022-10-07","current":-164.097087,"twenty":10.68803,"median":18.634848,"eighty":38.099501,"marketCap":8512044084},{"date":"2022-10-14","current":-160.9674,"twenty":10.587591,"median":18.478633,"eighty":38.099501,"marketCap":8349700975},{"date":"2022-10-21","current":-163.142472,"twenty":10.335342,"median":18.316363,"eighty":38.099501,"marketCap":8462526302},{"date":"2022-10-28","current":-173.909078,"twenty":10.256933,"median":18.205626,"eighty":38.099501,"marketCap":9021011669},{"date":"2022-11-04","current":-176.942094,"twenty":10.172528,"median":18.08264,"eighty":38.099501,"marketCap":9178340318},{"date":"2022-11-11","current":-502.564704,"twenty":-19.785503,"median":17.938028,"eighty":38.099501,"marketCap":9391426628},{"date":"2022-11-18","current":-495.926739,"twenty":-19.897812,"median":17.840364,"eighty":38.099501,"marketCap":9267382977},{"date":"2022-11-25","current":-515.537377,"twenty":-20.33003,"median":17.735721,"eighty":38.099501,"marketCap":9633846960},{"date":"2022-12-02","current":-529.857859,"twenty":-20.506906,"median":17.577624,"eighty":38.099501,"marketCap":9901453820},{"date":"2022-12-09","current":-511.999375,"twenty":-20.705138,"median":17.486049,"eighty":38.099501,"marketCap":9567732324},{"date":"2022-12-16","current":-531.441536,"twenty":-20.942856,"median":17.416425,"eighty":38.099501,"marketCap":9931047990},{"date":"2022-12-23","current":-529.655688,"twenty":-21.130464,"median":17.339807,"eighty":38.099501,"marketCap":9897675840},{"date":"2022-12-30","current":-536.799082,"twenty":-21.334291,"median":17.269055,"eighty":38.099501,"marketCap":10031164439},{"date":"2023-01-06","current":-535.046928,"twenty":-21.545832,"median":17.236563,"eighty":38.099501,"marketCap":9998421952},{"date":"2023-01-13","current":-527.22963,"twenty":-21.667149,"median":17.118203,"eighty":38.099501,"marketCap":9852340090},{"date":"2023-01-20","current":-529.824164,"twenty":-21.826877,"median":16.972593,"eighty":38.099501,"marketCap":9900824156},{"date":"2023-01-27","current":-524.197057,"twenty":-21.973079,"median":16.80081,"eighty":38.099501,"marketCap":9795670402},{"date":"2023-02-03","current":-524.432924,"twenty":-22.102169,"median":16.670289,"eighty":38.099501,"marketCap":9800078044},{"date":"2023-02-10","current":-505.462496,"twenty":-28.649453,"median":16.602573,"eighty":38.099501,"marketCap":9445577663},{"date":"2023-02-17","current":-497.779978,"twenty":-28.876431,"median":16.508241,"eighty":38.099501,"marketCap":9302014453},{"date":"2023-02-24","current":-484.70622,"twenty":-29.09929,"median":16.477034,"eighty":38.099501,"marketCap":9057705132},{"date":"2023-03-03","current":-41.301386,"twenty":-29.485826,"median":16.429048,"eighty":38.099501,"marketCap":9253988551},{"date":"2023-03-10","current":-37.89258,"twenty":-29.709809,"median":16.38135,"eighty":38.099501,"marketCap":8490211505},{"date":"2023-03-17","current":-38.197846,"twenty":-29.998588,"median":16.297694,"eighty":38.099501,"marketCap":8558609450},{"date":"2023-03-24","current":-39.933341,"twenty":-30.270138,"median":16.238273,"eighty":38.099501,"marketCap":8947464430},{"date":"2023-03-31","current":-41.360743,"twenty":-30.53607,"median":16.182497,"eighty":38.099029,"marketCap":9267288151},{"date":"2023-04-06","current":-41.205284,"twenty":-31.048081,"median":16.098301,"eighty":38.099029,"marketCap":9232455865},{"date":"2023-04-14","current":-41.202457,"twenty":-34.09955,"median":16.042513,"eighty":38.099501,"marketCap":9231822551},{"date":"2023-04-21","current":-40.967854,"twenty":-38.455061,"median":15.9108,"eighty":38.099501,"marketCap":9179257464},{"date":"2023-04-28","current":-39.300196,"twenty":-39.054853,"median":15.838594,"eighty":38.099501,"marketCap":8805602027},{"date":"2023-05-05","current":-38.692491,"twenty":-39.2985,"median":15.648764,"eighty":38.099501,"marketCap":8669439452},{"date":"2023-05-12","current":-55.552322,"twenty":-39.454526,"median":15.514786,"eighty":38.099974,"marketCap":8682105738},{"date":"2023-05-19","current":-53.956063,"twenty":-39.922035,"median":15.275654,"eighty":38.099974,"marketCap":8432631214},{"date":"2023-05-26","current":-52.236021,"twenty":-40.52861,"median":15.174543,"eighty":38.099974,"marketCap":8163811092},{"date":"2023-06-02","current":-52.878989,"twenty":-40.7129,"median":15.04752,"eighty":38.100446,"marketCap":8264298613},{"date":"2023-06-09","current":-52.252403,"twenty":-41.004034,"median":14.977267,"eighty":38.100446,"marketCap":8166371283},{"date":"2023-06-16","current":-52.801178,"twenty":-41.202457,"median":14.936073,"eighty":38.100918,"marketCap":8252137703},{"date":"2023-06-23","current":-52.440352,"twenty":-41.318345,"median":14.903002,"eighty":38.150016,"marketCap":8195745310},{"date":"2023-06-30","current":-50.753626,"twenty":-41.537685,"median":14.853104,"eighty":38.174566,"marketCap":7932131965},{"date":"2023-07-07","current":-50.138033,"twenty":-46.22859,"median":14.766074,"eighty":38.174566,"marketCap":7835922715},{"date":"2023-07-14","current":-52.021749,"twenty":-46.879568,"median":14.628077,"eighty":38.174566,"marketCap":8130323020},{"date":"2023-07-21","current":-52.567575,"twenty":-47.50686,"median":14.589694,"eighty":38.174566,"marketCap":8215628555},{"date":"2023-07-27","current":-53.663331,"twenty":-48.315997,"median":14.52007,"eighty":38.174566,"marketCap":8386881020},{"date":"2023-08-04","current":-53.166752,"twenty":-49.032684,"median":14.415054,"eighty":38.199115,"marketCap":8309272225},{"date":"2023-08-11","current":-98.649512,"twenty":-49.523974,"median":14.211824,"eighty":38.199115,"marketCap":8534563886},{"date":"2023-08-18","current":-100.649066,"twenty":-50.058815,"median":14.128435,"eighty":38.199115,"marketCap":8707553271},{"date":"2023-08-25","current":-101.269365,"twenty":-50.396977,"median":14.038531,"eighty":38.199115,"marketCap":8761217861},{"date":"2023-09-01","current":-104.618982,"twenty":-50.816236,"median":13.965497,"eighty":38.199115,"marketCap":9051006648},{"date":"2023-09-08","current":-99.050882,"twenty":-51.1829,"median":13.935856,"eighty":38.199115,"marketCap":8569288032},{"date":"2023-09-15","current":-97.657033,"twenty":-51.424475,"median":13.862451,"eighty":38.199115,"marketCap":8448700541},{"date":"2023-09-22","current":-96.86159,"twenty":-51.817934,"median":13.777431,"eighty":38.199115,"marketCap":8379883596},{"date":"2023-09-29","current":-95.620991,"twenty":-52.029354,"median":13.684192,"eighty":38.199115,"marketCap":8272554416},{"date":"2023-10-06","current":-93.555759,"twenty":-52.224357,"median":13.583697,"eighty":38.199115,"marketCap":8093882898},{"date":"2023-10-13","current":-93.424401,"twenty":-52.49593,"median":13.54653,"eighty":38.199115,"marketCap":8082518632},{"date":"2023-10-20","current":-96.350755,"twenty":-52.670695,"median":13.429195,"eighty":38.199115,"marketCap":8335689228},{"date":"2023-10-27","current":-94.051998,"twenty":-52.796263,"median":13.412728,"eighty":38.256711,"marketCap":8136814570},{"date":"2023-11-03","current":-94.022808,"twenty":-53.077759,"median":13.31981,"eighty":38.256711,"marketCap":8134289178},{"date":"2023-11-10","current":91.7495,"twenty":-53.156093,"median":13.244546,"eighty":38.432333,"marketCap":7335739502},{"date":"2023-11-17","current":95.899172,"twenty":-53.156093,"median":13.244546,"eighty":38.700486,"marketCap":7667522434},{"date":"2023-11-24","current":95.55271,"twenty":-53.156093,"median":13.244546,"eighty":38.883662,"marketCap":7639821392},{"date":"2023-12-01","current":93.095978,"twenty":-53.156093,"median":13.244546,"eighty":39.035206,"marketCap":7443395823},{"date":"2023-12-08","current":94.135365,"twenty":-53.153908,"median":13.248728,"eighty":39.308081,"marketCap":7526498949},{"date":"2023-12-15","current":96.867692,"twenty":-53.153908,"median":13.248728,"eighty":39.543187,"marketCap":7744959437},{"date":"2023-12-22","current":95.355857,"twenty":-53.153908,"median":13.248728,"eighty":39.773572,"marketCap":7624082164},{"date":"2023-12-29","current":97.135413,"twenty":-53.156093,"median":13.244546,"eighty":40.05636,"marketCap":7766364787},{"date":"2024-01-05","current":97.914953,"twenty":-53.158278,"median":13.216206,"eighty":40.466144,"marketCap":7828692131},{"date":"2024-01-12","current":94.804667,"twenty":-53.158278,"median":13.216206,"eighty":42.631172,"marketCap":7580012325},{"date":"2024-01-19","current":90.702239,"twenty":-53.160463,"median":13.187866,"eighty":44.499321,"marketCap":7252006808},{"date":"2024-01-26","current":96.710209,"twenty":-53.158278,"median":13.216206,"eighty":44.912837,"marketCap":7732368054},{"date":"2024-02-02","current":97.387385,"twenty":-53.158278,"median":13.216206,"eighty":45.434552,"marketCap":7786510999},{"date":"2024-02-09","current":96.592097,"twenty":-53.158278,"median":13.216206,"eighty":45.838119,"marketCap":7722924517},{"date":"2024-02-16","current":99.859866,"twenty":-53.158278,"median":13.216206,"eighty":46.267803,"marketCap":7984195706},{"date":"2024-02-23","current":101.143351,"twenty":-53.158278,"median":13.216206,"eighty":46.765266,"marketCap":8086815474},{"date":"2024-03-01","current":18.04484,"twenty":-53.156093,"median":13.244546,"eighty":46.893984,"marketCap":7485576955},{"date":"2024-03-08","current":17.489298,"twenty":-53.156093,"median":13.244546,"eighty":46.893984,"marketCap":7255120582},{"date":"2024-03-15","current":17.779359,"twenty":-53.156093,"median":13.244546,"eighty":46.893984,"marketCap":7375446978},{"date":"2024-03-22","current":18.651043,"twenty":-53.156093,"median":13.244546,"eighty":46.893984,"marketCap":7737049620},{"date":"2024-03-28","current":18.111501,"twenty":-53.156093,"median":13.244546,"eighty":46.893984,"marketCap":7513230054},{"date":"2024-04-05","current":17.314961,"twenty":-53.158278,"median":13.216206,"eighty":46.912018,"marketCap":7182800054},{"date":"2024-04-12","current":17.056462,"twenty":-53.158278,"median":13.216206,"eighty":46.912018,"marketCap":7075566167},{"date":"2024-04-19","current":16.422236,"twenty":-53.158278,"median":13.216206,"eighty":46.912018,"marketCap":6812469073},{"date":"2024-04-26","current":16.145702,"twenty":-53.156093,"median":13.244546,"eighty":46.893984,"marketCap":6697753752},{"date":"2024-05-03","current":20.598064,"twenty":-53.156093,"median":13.244546,"eighty":46.893984,"marketCap":6813715979},{"date":"2024-05-10","current":21.557349,"twenty":-53.156093,"median":13.244546,"eighty":46.893984,"marketCap":7131041588},{"date":"2024-05-17","current":21.056148,"twenty":-53.156093,"median":13.244546,"eighty":46.893984,"marketCap":6965247392},{"date":"2024-05-24","current":19.80791,"twenty":-53.156093,"median":13.244546,"eighty":46.893984,"marketCap":6552337894},{"date":"2024-05-31","current":20.097578,"twenty":-53.156093,"median":13.244546,"eighty":46.893984,"marketCap":6648158114},{"date":"2024-06-07","current":20.261468,"twenty":-53.156093,"median":13.244546,"eighty":46.893984,"marketCap":6702372185},{"date":"2024-06-14","current":21.477309,"twenty":-53.158278,"median":13.216206,"eighty":46.912018,"marketCap":7104564948},{"date":"2024-06-21","current":20.467042,"twenty":-53.160463,"median":13.187866,"eighty":46.930051,"marketCap":6770374540},{"date":"2024-06-28","current":20.417475,"twenty":-53.16429,"median":13.168817,"eighty":46.974201,"marketCap":6753978327},{"date":"2024-07-05","current":19.736893,"twenty":-53.16429,"median":13.168817,"eighty":46.974201,"marketCap":6528845716},{"date":"2024-07-12","current":20.215398,"twenty":-53.16429,"median":13.168817,"eighty":46.974201,"marketCap":6687132230},{"date":"2024-07-15","current":20.12961,"twenty":-53.16429,"median":13.168817,"eighty":46.974201,"marketCap":6658754170},{"date":"2024-08-02","current":17.885382,"twenty":-53.178465,"median":12.842617,"eighty":47.17374,"marketCap":7063366473},{"date":"2024-08-09","current":17.664903,"twenty":-53.178465,"median":12.906324,"eighty":47.17374,"marketCap":6976294024},{"date":"2024-08-16","current":17.200489,"twenty":-53.178465,"median":13.187866,"eighty":47.17374,"marketCap":6792886100},{"date":"2024-08-23","current":17.911964,"twenty":-53.178465,"median":13.324456,"eighty":47.17374,"marketCap":7073864570},{"date":"2024-08-30","current":18.076151,"twenty":-53.178465,"median":13.415515,"eighty":47.17374,"marketCap":7138705756},{"date":"2024-09-06","current":16.948737,"twenty":-53.178465,"median":13.500071,"eighty":47.17374,"marketCap":6693462948},{"date":"2024-09-13","current":16.645383,"twenty":-53.178465,"median":13.566043,"eighty":47.17374,"marketCap":6573661139},{"date":"2024-09-20","current":17.402204,"twenty":-53.178465,"median":13.629227,"eighty":47.17374,"marketCap":6872548127},{"date":"2024-09-27","current":17.230199,"twenty":-53.178465,"median":13.761171,"eighty":47.17374,"marketCap":6804619266},{"date":"2024-10-04","current":16.975319,"twenty":-53.178465,"median":13.812276,"eighty":47.17374,"marketCap":6703961045},{"date":"2024-10-11","current":16.867425,"twenty":-53.178465,"median":13.882893,"eighty":47.17374,"marketCap":6661351123},{"date":"2024-10-18","current":17.924474,"twenty":-53.178465,"median":13.959086,"eighty":47.17374,"marketCap":7078804851},{"date":"2024-10-25","current":16.895572,"twenty":-53.178465,"median":14.035279,"eighty":47.17374,"marketCap":6672466755},{"date":"2024-10-31","current":17.69774,"twenty":-53.178465,"median":14.148639,"eighty":47.17374,"marketCap":6989262261},{"date":"2024-11-08","current":15.543113,"twenty":-53.203679,"median":14.578693,"eighty":47.175246,"marketCap":7198932815},{"date":"2024-11-15","current":16.220547,"twenty":-53.203679,"median":16.183124,"eighty":47.175246,"marketCap":7512692147},{"date":"2024-11-22","current":16.328884,"twenty":-53.203679,"median":16.250003,"eighty":47.175246,"marketCap":7562869459},{"date":"2024-11-29","current":15.870735,"twenty":-53.203679,"median":16.304172,"eighty":47.175246,"marketCap":7350673841},{"date":"2024-12-06","current":16.073051,"twenty":-53.203679,"median":16.304172,"eighty":47.175246,"marketCap":7444378458},{"date":"2024-12-13","current":16.133094,"twenty":-53.203679,"median":16.304172,"eighty":47.175246,"marketCap":7472187571},{"date":"2024-12-20","current":16.035199,"twenty":-53.203679,"median":16.33541,"eighty":47.175246,"marketCap":7426846627},{"date":"2024-12-27","current":16.422863,"twenty":-53.203679,"median":16.349022,"eighty":47.175246,"marketCap":7606396765},{"date":"2025-01-03","current":16.153978,"twenty":-53.203679,"median":16.349022,"eighty":47.175246,"marketCap":7481860305},{"date":"2025-01-10","current":15.693219,"twenty":-53.228893,"median":16.356108,"eighty":47.176752,"marketCap":7268455596},{"date":"2025-01-17","current":16.005178,"twenty":-53.228893,"median":16.356108,"eighty":47.176752,"marketCap":7412942071},{"date":"2025-01-24","current":15.986904,"twenty":-53.228893,"median":16.356108,"eighty":47.176752,"marketCap":7404478428},{"date":"2025-01-31","current":16.322357,"twenty":-53.228893,"median":16.356108,"eighty":47.176752,"marketCap":7559846729},{"date":"2025-02-07","current":15.672335,"twenty":-53.228893,"median":16.356108,"eighty":47.176752,"marketCap":7258782861},{"date":"2025-02-14","current":17.858656,"twenty":-53.228893,"median":16.422863,"eighty":47.176752,"marketCap":8271397277},{"date":"2025-02-21","current":17.836467,"twenty":-53.228893,"median":16.522931,"eighty":47.176752,"marketCap":8261119996},{"date":"2025-02-28","current":15.534425,"twenty":-53.228893,"median":16.592548,"eighty":47.176752,"marketCap":8701142266},{"date":"2025-03-07","current":14.794949,"twenty":-53.254107,"median":16.605832,"eighty":47.178258,"marketCap":8286946759},{"date":"2025-03-14","current":14.751578,"twenty":-53.254107,"median":16.605832,"eighty":47.178258,"marketCap":8262653767},{"date":"2025-03-21","current":15.241671,"twenty":-53.254107,"median":16.605832,"eighty":47.178258,"marketCap":8537164573},{"date":"2025-03-28","current":13.705251,"twenty":-53.254107,"median":16.605832,"eighty":47.178258,"marketCap":7676585345},{"date":"2025-04-04","current":13.100225,"twenty":-53.254107,"median":16.631892,"eighty":47.178258,"marketCap":7337698112},{"date":"2025-04-11","current":11.065039,"twenty":-53.228893,"median":16.619117,"eighty":47.176752,"marketCap":6197749481},{"date":"2025-04-17","current":11.010825,"twenty":-53.228893,"median":16.619117,"eighty":47.176752,"marketCap":6167383242},{"date":"2025-04-25","current":11.816442,"twenty":-53.254107,"median":16.631892,"eighty":47.178258,"marketCap":6618625561},{"date":"2025-05-02","current":12.705549,"twenty":-53.254107,"median":16.631892,"eighty":47.178258,"marketCap":7116631889},{"date":"2025-05-09","current":12.578444,"twenty":-53.254107,"median":16.502641,"eighty":47.178258,"marketCap":6065287882},{"date":"2025-05-16","current":13.55752,"twenty":-53.254107,"median":16.394433,"eighty":47.178258,"marketCap":6537395444},{"date":"2025-05-23","current":13.78056,"twenty":-53.254107,"median":16.300908,"eighty":47.178258,"marketCap":6644944752},{"date":"2025-05-30","current":13.837439,"twenty":-53.254107,"median":16.231641,"eighty":47.178258,"marketCap":6672371366},{"date":"2025-06-06","current":13.90646,"twenty":-53.254107,"median":16.150062,"eighty":47.178258,"marketCap":6705653100},{"date":"2025-06-13","current":13.840947,"twenty":-53.254107,"median":16.122651,"eighty":47.178258,"marketCap":6674063061},{"date":"2025-06-20","current":13.583064,"twenty":-53.279321,"median":16.075662,"eighty":47.179764,"marketCap":6549712913},{"date":"2025-06-27","current":13.491457,"twenty":-53.279321,"median":16.050862,"eighty":47.179764,"marketCap":6505539867},{"date":"2025-07-03","current":13.734908,"twenty":-53.279321,"median":16.005178,"eighty":47.179764,"marketCap":6622931248},{"date":"2025-07-11","current":14.115143,"twenty":-53.279321,"median":15.929472,"eighty":47.179764,"marketCap":6806279642},{"date":"2025-07-18","current":14.41381,"twenty":-53.279321,"median":15.877262,"eighty":47.179764,"marketCap":6950295872},{"date":"2025-07-25","current":14.809104,"twenty":-53.279321,"median":15.862904,"eighty":47.179764,"marketCap":7140905588},{"date":"2025-08-01","current":14.384947,"twenty":-53.279321,"median":15.767619,"eighty":47.179764,"marketCap":6936378337},{"date":"2025-08-08","current":-16.793357,"twenty":-53.279321,"median":15.682777,"eighty":47.000318,"marketCap":6798639312},{"date":"2025-08-15","current":-17.481093,"twenty":-53.279321,"median":15.543113,"eighty":46.621623,"marketCap":7077063246},{"date":"2025-08-22","current":-18.059451,"twenty":-53.279321,"median":15.248123,"eighty":46.204377,"marketCap":7311206248},{"date":"2025-08-29","current":-18.89852,"twenty":-53.279321,"median":15.126737,"eighty":45.587522,"marketCap":7650895579},{"date":"2025-09-05","current":-19.181705,"twenty":-53.304535,"median":15.002046,"eighty":45.2536,"marketCap":7765540728},{"date":"2025-09-12","current":-19.247632,"twenty":-53.279321,"median":14.836712,"eighty":44.718206,"marketCap":7792230604},{"date":"2025-09-19","current":-19.656678,"twenty":-53.279321,"median":14.725026,"eighty":44.34573,"marketCap":7957829152},{"date":"2025-09-26","current":-19.148742,"twenty":-53.279321,"median":14.569418,"eighty":40.738074,"marketCap":7752195790},{"date":"2025-10-03","current":-20.558677,"twenty":-53.279321,"median":14.384947,"eighty":40.071467,"marketCap":8322995182},{"date":"2025-10-10","current":-20.69952,"twenty":-53.279321,"median":14.136476,"eighty":39.734388,"marketCap":8380014463},{"date":"2025-10-17","current":-20.115169,"twenty":-53.279321,"median":14.03172,"eighty":39.526191,"marketCap":8143445108},{"date":"2025-10-24","current":-20.704015,"twenty":-53.279321,"median":13.984633,"eighty":39.242459,"marketCap":8381834227},{"date":"2025-10-31","current":-20.422328,"twenty":-53.279321,"median":13.841273,"eighty":38.983275,"marketCap":8267795666},{"date":"2025-11-07","current":-22.105611,"twenty":-53.279321,"median":13.813153,"eighty":38.805293,"marketCap":8145563799},{"date":"2025-11-14","current":-23.368788,"twenty":-53.279321,"median":13.734908,"eighty":38.545165,"marketCap":8611024588},{"date":"2025-11-21","current":-28.98053,"twenty":-53.279321,"median":13.677668,"eighty":38.199115,"marketCap":10678861485},{"date":"2025-11-28","current":-29.110805,"twenty":-53.279321,"median":13.566751,"eighty":37.947957,"marketCap":10726865927},{"date":"2025-12-05","current":-27.524412,"twenty":-53.279321,"median":13.491457,"eighty":21.822096,"marketCap":10142305511},{"date":"2025-12-12","current":-27.191303,"twenty":-53.279321,"median":13.397339,"eighty":21.576295,"marketCap":10019559977},{"date":"2025-12-19","current":-27.374348,"twenty":-53.279321,"median":13.016736,"eighty":21.514646,"marketCap":10087009256},{"date":"2025-12-26","current":-28.165895,"twenty":-53.279321,"median":12.681695,"eighty":21.393745,"marketCap":10378681812},{"date":"2026-01-02","current":-28.033971,"twenty":-53.279321,"median":12.240394,"eighty":21.314409,"marketCap":10330069720},{"date":"2026-01-09","current":-26.42614,"twenty":-53.279321,"median":11.594165,"eighty":21.186117,"marketCap":9737609839},{"date":"2026-01-16","current":-28.225261,"twenty":-53.279321,"median":11.144191,"eighty":21.061342,"marketCap":10400557254},{"date":"2026-01-23","current":-28.198877,"twenty":-53.279321,"median":10.896976,"eighty":20.978505,"marketCap":10390834836},{"date":"2026-01-30","current":-27.041238,"twenty":-53.279321,"median":-16.793357,"eighty":20.914814,"marketCap":9964263721},{"date":"2026-02-06","current":-26.904367,"twenty":-53.279321,"median":-17.630927,"eighty":20.882423,"marketCap":9913828675},{"date":"2026-02-13","current":-27.422171,"twenty":-53.279321,"median":-18.446022,"eighty":20.844049,"marketCap":10104631139},{"date":"2026-02-20","current":-27.96636,"twenty":-53.279321,"median":-18.762171,"eighty":20.786302,"marketCap":10305156022},{"date":"2026-02-27","current":-32.663554,"twenty":-53.279321,"median":-19.028875,"eighty":20.659971,"marketCap":11633059339},{"date":"2026-03-06","current":-31.740532,"twenty":-53.279321,"median":-19.247632,"eighty":20.595211,"marketCap":11304327070},{"date":"2026-03-13","current":-31.168397,"twenty":-53.279321,"median":-19.409452,"eighty":20.496744,"marketCap":11100562312},{"date":"2026-03-20","current":-31.424216,"twenty":-53.279321,"median":-19.653443,"eighty":20.433288,"marketCap":11191671630}],"updateTime":1774193091593},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"JAZZ\",pageSize:20,pageCount:4,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2602518318","title":"Press Release: Jazz Pharmaceuticals Appoints Thomas Riga as Chief Business Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2602518318","media":"Dow Jones","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602518318?lang=en_us&edition=fundamental","pubTime":"2026-01-09 05:05","pubTimestamp":1767906300,"startTime":"0","endTime":"0","summary":"Mr. Riga brings over 25 years of commercial and operational experience with proven success leading transformative corporate development strategies and transactions. DUBLIN, Jan. 8, 2026 /PRNewswire/ -- Jazz Pharmaceuticals plc  today announced the appointment of Thomas Riga as Chief Business Officer, effective January 1, 2026.\"I am honored to take on this new role of chief business officer at Jazz, \" said Mr. Riga. \"I've been impressed by the strength and vision of Jazz's leadership team and look forward to advancing the company through innovative strategic transactions that leverage the existing expertise and capabilities of the company. Together, we will continue to build on our proven corporate development engine to deliver shareholder value and, most importantly, make a meaningful impact for patients with unmet medical need.\". Jazz Pharmaceuticals plc  is a global biopharma company whose purpose is to innovate to transform the lives of patients and their families. We are dedicated ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4604","BK4007","IE00BN0W2T93.GBP","LU0154245673.USD","BK4585","03160","BK4099","IE00BN0W2W23.USD","BK4588","JAZZ","LU0320765992.SGD","BK4533","LU0889565916.HKD","BK4555","IE00BN0W2V16.EUR","LU0109394709.USD","LU0823416689.USD","TM","LU0154245756.USD","BK4532"],"gpt_icon":0},{"id":"2601692583","title":"RBC Trims Price Target on Jazz Pharmaceuticals to $191 From $194, Keeps Outperform Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2601692583","media":"MT Newswires Live","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601692583?lang=en_us&edition=fundamental","pubTime":"2026-01-08 20:26","pubTimestamp":1767875216,"startTime":"0","endTime":"0","summary":"Jazz Pharmaceuticals (JAZZ)  has an average rating of buy and mean price target of $215.27, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from ma","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0889565916.HKD","LU0154245673.USD","BK4533","BK4532","LU0320765992.SGD","BK4007","IE00BN0W2W23.USD","LU0109394709.USD","IE00BN0W2T93.GBP","JAZZ","LU0823416689.USD","IE00BN0W2V16.EUR","LU0154245756.USD"],"gpt_icon":0},{"id":"2601383883","title":"Jazz Pharmaceuticals' Drug Extends Survival Past Two Years in Advanced Stomach Cancer Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2601383883","media":"Benzinga_recent_news","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601383883?lang=en_us&edition=fundamental","pubTime":"2026-01-08 02:12","pubTimestamp":1767809520,"startTime":"0","endTime":"0","summary":"Jazz Pharmaceuticals reported Phase 3 trial results showing Ziihera helped patients with advanced HER2-positive stomach cancer live longer, with some treatments pushing survival beyond two years.","market":"sh","thumbnail":"https://cdn.benzinga.com/files/images/story/2026/01/07/cancer.jpeg?optimize=medium&dpr=2&auto=webp&width=240","type":0,"news_type":0,"thumbnails":["https://cdn.benzinga.com/files/images/story/2026/01/07/cancer.jpeg?optimize=medium&dpr=2&auto=webp&width=240"],"rights":{"source":"benzinga_recent_news","url":"https://www.benzinga.com/news/financing/26/01/49763409/jazz-pharmaceuticals-drug-extends-survival-past-two-years-in-advanced-stomach-cancer-trial","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/financing/26/01/49763409/jazz-pharmaceuticals-drug-extends-survival-past-two-years-in-advanced-stomach-cancer-trial","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"benzinga_recent_news","symbols":["IE0031619046.USD","BK4195","LU0109394709.USD","BK4157","LU0154245673.USD","BK4532","LU0757428866.USD","AEIS","BK4211","IE00B7SZL793.SGD","LU0320765992.SGD","BK4007","IE00BN0W2W23.USD","IE00B66KJ199.SGD","BK4533","ONC","BK4585","PFS","IE00BN0W2V16.EUR","IE00B19Z4B17.USD","LU0154245756.USD","LU0889565916.HKD","OS","LU1815336091.USD","JAZZ","BK4526","ZYME","LU0823416689.USD","IE00BN0W2T93.GBP","BK4097","BK4139"],"gpt_icon":0},{"id":"2601812475","title":"Jazz Pharmaceuticals Reports Phase 3 Success for Ziihera in First-Line HER2+ Metastatic GEA","url":"https://stock-news.laohu8.com/highlight/detail?id=2601812475","media":"Reuters","labels":["productRelease","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601812475?lang=en_us&edition=fundamental","pubTime":"2026-01-07 02:33","pubTimestamp":1767724385,"startTime":"0","endTime":"0","summary":"Jazz Pharmaceuticals plc has announced positive efficacy and safety results from the Phase 3 HERIZON-GEA-01 trial evaluating Ziihera  in combination with chemotherapy, with or without the PD-1 inhibitor Tevimbra , as a first-line treatment for HER2-positive locally advanced or metastatic gastroesophageal adenocarcinoma . The study demonstrated that both investigational arms—Ziihera plus tislelizumab and chemotherapy, and Ziihera plus chemotherapy—resulted in a statistically significant and clinically meaningful prolongation of progression-free survival compared to trastuzumab plus chemotherapy, with approximately a 35% reduction in the risk of disease progression or death and a median progression-free survival of more than one year. These late-breaking results will be presented at the 2026 ASCO Gastrointestinal Cancers Symposium  on January 8, 2026.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide acc","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260106:nNDL8ylPng:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0889565916.HKD","BK4533","LU0154245673.USD","IE00BN0W2V16.EUR","JAZZ","LU0823416689.USD","BK4007","LU0109394709.USD","IE00BN0W2T93.GBP","LU0154245756.USD","BK4532","LU0320765992.SGD","IE00BN0W2W23.USD"],"gpt_icon":0},{"id":"2601812427","title":"Ziihera® (Zanidatamab-Hrii) Combinations Achieve Unprecedented Results in First-Line Her2+ Locally Advanced or Metastatic Gea Including More Than Two Years Median Overall Survival Benefit","url":"https://stock-news.laohu8.com/highlight/detail?id=2601812427","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601812427?lang=en_us&edition=fundamental","pubTime":"2026-01-07 02:32","pubTimestamp":1767724378,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260106:nFWN3Y70DD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0889565916.HKD","LU0320765992.SGD","IE00BN0W2T93.GBP","IE00BN0W2V16.EUR","BK4533","BK4532","JAZZ","BK4007","LU0823416689.USD","LU0154245756.USD","LU0154245673.USD","IE00BN0W2W23.USD","LU0109394709.USD"],"gpt_icon":0},{"id":"2601244812","title":"Jazz Pharmaceuticals Plc: Additional Planned Os Interim Analysis for Ziihera Plus Chemotherapy Is Currently Expected in Mid-2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2601244812","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601244812?lang=en_us&edition=fundamental","pubTime":"2026-01-07 02:32","pubTimestamp":1767724378,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260106:nFWN3Y70DD:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0154245756.USD","IE00BN0W2W23.USD","IE00BN0W2V16.EUR","BK4007","LU0109394709.USD","LU0154245673.USD","LU0889565916.HKD","JAZZ","BK4533","LU0320765992.SGD","BK4532","LU0823416689.USD","IE00BN0W2T93.GBP"],"gpt_icon":0},{"id":"2592794342","title":"Jazz Pharmaceuticals to Present Phase 3 Zanidatamab Trial Results at Investor Webcast","url":"https://stock-news.laohu8.com/highlight/detail?id=2592794342","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592794342?lang=en_us&edition=fundamental","pubTime":"2025-12-18 05:15","pubTimestamp":1766006141,"startTime":"0","endTime":"0","summary":"Jazz Pharmaceuticals plc will host an investor webcast on Friday, January 9, 2026, to review results from the Phase 3 zanidatamab HERIZON-GEA-01 trial, following its presentation at the ASCO Gastrointestinal Cancers Symposium. Additionally, the company will present at the 44th Annual J.P. Morgan Healthcare Conference on Tuesday, January 13, 2026. Audio webcasts of both events will be available on the Jazz Pharmaceuticals website.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Jazz Pharmaceuticals plc published the original content used to generate this news brief via PR Newswire  on December 17, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251217:nNDLb3F7pY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0109394709.USD","LU0823416689.USD","LU0320765992.SGD","LU0889565916.HKD","BK4532","IE00BN0W2W23.USD","IE00BN0W2T93.GBP","BK4533","JAZZ","IE00BN0W2V16.EUR","BK4007"],"gpt_icon":0},{"id":"2591869360","title":"Jazz Pharmaceuticals (JAZZ): Valuation Check After Positive Ziihera and Epidiolex Clinical Updates Boost Investor Interest","url":"https://stock-news.laohu8.com/highlight/detail?id=2591869360","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2591869360?lang=en_us&edition=fundamental","pubTime":"2025-12-15 07:22","pubTimestamp":1765754521,"startTime":"0","endTime":"0","summary":"Jazz Pharmaceuticals (JAZZ) has slipped onto more investors radar after a run of encouraging clinical updates, from fresh Epidiolex seizure data to promising Ziihera results in HER2 positive gastroesophageal cancer and upcoming conference showcases.\nSee our latest analysis for Jazz Pharmaceuticals.\nThose updates seem to be resonating with investors, with the share price now at $167.50 and a strong 30 day share price return of 18.74 percent feeding into a 36.13 percent 1 year total shareholder...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-jazz/jazz-pharmaceuticals/news/jazz-pharmaceuticals-jazz-valuation-check-after-positive-zii","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-jazz/jazz-pharmaceuticals/news/jazz-pharmaceuticals-jazz-valuation-check-after-positive-zii","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4007","BK4532","IE00BN0W2V16.EUR","IE00BN0W2W23.USD","JAZZ","LU0823416689.USD","LU0889565916.HKD","LU0320765992.SGD","IE00BN0W2T93.GBP","BK4533","LU0109394709.USD"],"gpt_icon":0},{"id":"2590725544","title":"Jazz Pharmaceuticals SVP Technical Operations Mary Elizabeth Henderson Reports Sale of Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2590725544","media":"Reuters","labels":["shareholding","insiderTrades","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590725544?lang=en_us&edition=fundamental","pubTime":"2025-12-12 06:20","pubTimestamp":1765491608,"startTime":"0","endTime":"0","summary":"Mary Elizabeth Henderson, Senior Vice President of Technical Operations at Jazz Pharmaceuticals plc, reported a disposal of common shares of the company. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Jazz Pharmaceuticals plc published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on December 11, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251211:nNDL2SjJgs:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Jazz Pharmaceuticals SVP Technical Operations Mary Elizabeth Henderson Reports Sale of Common Shares","news_tag":"shareholding,insiderTrades,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["JAZZ","LU0320765992.SGD","IE00BN0W2V16.EUR","BK4533","BK4532","IE00BN0W2W23.USD","LU0889565916.HKD","LU0823416689.USD","IE00BN0W2T93.GBP","LU0109394709.USD","BK4007"],"gpt_icon":0},{"id":"2590315345","title":"Jazz Pharmaceuticals Price Target Raised to $219.00/Share From $147.00 by Piper Sandler","url":"https://stock-news.laohu8.com/highlight/detail?id=2590315345","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590315345?lang=en_us&edition=fundamental","pubTime":"2025-12-11 00:57","pubTimestamp":1765385820,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/JAZZ/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  December 10, 2025 11:57 ET (16:57 GMT)","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","LU0109394709.USD","LU0889565916.HKD","IE00BN0W2V16.EUR","IE00BN0W2W23.USD","BK4532","BK4533","LU0823416689.USD","IE00BN0W2T93.GBP","LU0320765992.SGD","JAZZ"],"gpt_icon":0},{"id":"2590322068","title":"Jazz Pharmaceuticals SVP Chief Accounting Officer Patricia Carr Reports Disposal of Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2590322068","media":"Reuters","labels":["shareholding","insiderTrades","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590322068?lang=en_us&edition=fundamental","pubTime":"2025-12-10 06:25","pubTimestamp":1765319154,"startTime":"0","endTime":"0","summary":"Patricia Carr, Senior Vice President and Chief Accounting Officer of Jazz Pharmaceuticals plc, has reported a disposal of common shares of the company. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Jazz Pharmaceuticals plc published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on December 09, 2025, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251209:nNDL5PnJl9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Jazz Pharmaceuticals SVP Chief Accounting Officer Patricia Carr Reports Disposal of Common Shares","news_tag":"shareholding,insiderTrades,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BN0W2V16.EUR","IE00BN0W2T93.GBP","LU0320765992.SGD","LU0889565916.HKD","BK4533","JAZZ","BK4007","IE00BN0W2W23.USD","BK4532","LU0823416689.USD","LU0109394709.USD"],"gpt_icon":0},{"id":"2589181855","title":"Jazz Pharmaceuticals Highlights New Epidiolex Data in Treatment-Resistant Epilepsies at AES 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2589181855","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2589181855?lang=en_us&edition=fundamental","pubTime":"2025-12-05 22:00","pubTimestamp":1764943254,"startTime":"0","endTime":"0","summary":"Jazz Pharmaceuticals plc announced that eight abstracts, including four late-breaking presentations, will be featured at the upcoming American Epilepsy Society  2025 Annual Meeting, scheduled for December 5-9, 2025, in Atlanta, Georgia. The presentations will focus on new data and real-world evidence related to Epidiolex  for treatment-resistant epilepsies. Notably, interim results from the EpiCom trial, which evaluated behavioral outcomes in patients with tuberous sclerosis complex, suggest improvements in non-seizure outcomes. Additional real-world studies using data from the U.S. Optum Market Clarity Database indicate that Epidiolex initiation in cannabidiol-nave patients with Dravet Syndrome, Lennox-Gastaut Syndrome, or tuberous sclerosis complex is associated with reduced polypharmacy and healthcare resource utilization at 12 months, with further reductions observed among early-line initiators. All results are scheduled to be presented at the AES 2025 Annual Meeting.Disclaimer: Th","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251205:nNDL2FWDgv:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","LU0109394709.USD","LU0889565916.HKD","IE00BN0W2V16.EUR","IE00BN0W2W23.USD","BK4532","BK4533","LU0823416689.USD","IE00BN0W2T93.GBP","LU0320765992.SGD","JAZZ"],"gpt_icon":0},{"id":"2588066976","title":"Jazz Pharmaceuticals Announces Positive Phase 3 Results for Ziihera in HER2-Positive Gastroesophageal Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2588066976","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588066976?lang=en_us&edition=fundamental","pubTime":"2025-12-03 05:05","pubTimestamp":1764709536,"startTime":"0","endTime":"0","summary":"Jazz Pharmaceuticals plc has announced that pivotal Phase 3 results from the HERIZON-GEA-01 study evaluating Ziihera  combinations in first-line HER2-positive locally advanced or metastatic gastroesophageal adenocarcinoma will be presented at the 2026 American Society of Clinical Oncology Gastrointestinal Cancers Symposium , scheduled for January 8-10, 2026, in San Francisco. The late-breaking presentation will highlight data on Ziihera in combination with chemotherapy, with or without the PD-1 inhibitor Tevimbra . According to the company, both Ziihera plus chemotherapy and Ziihera plus tislelizumab and chemotherapy demonstrated statistically significant and clinically meaningful improvements in progression-free survival compared to the control arm of trastuzumab plus chemotherapy. The combination with tislelizumab also showed statistically significant improvement in overall survival. The results will be presented during an oral abstract session on January 8, 2026.Disclaimer: This new","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251202:nNDL2Ltc1P:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0109394709.USD","LU0823416689.USD","JAZZ","BK4533","BK4532","IE00BN0W2V16.EUR","LU0320765992.SGD","BK4007","IE00BN0W2W23.USD","LU0889565916.HKD","IE00BN0W2T93.GBP"],"gpt_icon":0},{"id":"2586621476","title":"Saniona AB Q3 2025 revenue surged to SEK 410.7 million, nearly 57 times higher","url":"https://stock-news.laohu8.com/highlight/detail?id=2586621476","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586621476?lang=en_us&edition=fundamental","pubTime":"2025-11-27 15:00","pubTimestamp":1764226851,"startTime":"0","endTime":"0","summary":"Saniona AB reported revenue of SEK 410.7 million for the third quarter  2025 and SEK 429.8 million for the nine months ended September 30, 2025. Operating profit reached SEK 359.9 million in Q3 2025, with an operating profit of SEK 317.5 million for the nine-month period. Net profit for Q3 2025 was SEK 329.6 million, while net profit for the nine months ended September 30, 2025 was SEK 326.3 million. Cash and cash equivalents totaled SEK 672.8 million as of September 30, 2025. Basic earnings per share were SEK 2.39 for Q3 2025 and SEK 2.56 for the nine-month period. Diluted earnings per share were SEK 2.35 in Q3 2025 and SEK 2.52 for the nine months ended September 30, 2025. The financial results for the period were positively impacted by an upfront payment from a licensing and partnership agreement with Jazz Pharmaceuticals.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251127:nNDL2ZWX7v:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","JAZZ","IE00BN0W2W23.USD","LU0823416689.USD","IE00BN0W2V16.EUR","LU0320765992.SGD","IE00BN0W2T93.GBP","LU0889565916.HKD","BK4532","LU0109394709.USD","BK4533"],"gpt_icon":0},{"id":"2586841569","title":"Director Heather Ann McSharry Reports Disposal of Jazz Pharmaceuticals plc Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2586841569","media":"Reuters","labels":["shareholding","insiderTrades","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586841569?lang=en_us&edition=fundamental","pubTime":"2025-11-25 06:48","pubTimestamp":1764024503,"startTime":"0","endTime":"0","summary":"Heather Ann McSharry, Director at Jazz Pharmaceuticals plc, reported a disposal of common shares of the company, according to a recent SEC filing. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Jazz Pharmaceuticals plc published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on November 24, 2025, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251124:nNDLbKLkfj:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Director Heather Ann McSharry Reports Disposal of Jazz Pharmaceuticals plc Common Shares","news_tag":"shareholding,insiderTrades,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0109394709.USD","IE00BN0W2W23.USD","LU0889565916.HKD","JAZZ","LU0320765992.SGD","BK4533","IE00BN0W2V16.EUR","LU0823416689.USD","BK4007","BK4532","IE00BN0W2T93.GBP"],"gpt_icon":0},{"id":"2586496706","title":"Jazz Gains From Ziihera Data, Upside Seen as Priced In, UBS Says","url":"https://stock-news.laohu8.com/highlight/detail?id=2586496706","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586496706?lang=en_us&edition=fundamental","pubTime":"2025-11-25 00:37","pubTimestamp":1764002221,"startTime":"0","endTime":"0","summary":"Jazz Pharmaceuticals  received a boost from positive topline data from a late-stage study of Ziihera in gastro-esophageal adenocarcinoma, which uplifts the company's oncology revenue outlook but is largely priced in, UBS Securities said in a note Monday.The study showed statistically significant and clinically meaningful improvements in progression-free and overall survival for Ziihera in combination with chemotherapy, with or without the PD-1 inhibitor tislelizumab. Jazz plans to submit a supplemental Biologics License Application for this indication in the US in the first half of 2026.UBS raised its Ziihera peak sales assumption to about $1.5 billion from its prior guidance of $730 million.Despite the oncology upside, the investment firm flagged headwinds in the sleep franchise, citing intensifying competition and pressure from generic drugs.UBS now models a 2026 to 2029 EPS compound annual growth rate of about 8% and said the stock's current valuation already reflects much of the Zi","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4007","LU0320765992.SGD","BK4533","BK4532","IE00BN0W2V16.EUR","IE00BN0W2W23.USD","LU0823416689.USD","JAZZ","LU0109394709.USD","LU0889565916.HKD","IE00BN0W2T93.GBP"],"gpt_icon":0},{"id":"2585467623","title":"Jazz Pharmaceuticals Cut to Neutral From Buy by UBS","url":"https://stock-news.laohu8.com/highlight/detail?id=2585467623","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2585467623?lang=en_us&edition=fundamental","pubTime":"2025-11-24 21:39","pubTimestamp":1763991540,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/JAZZ/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  November 24, 2025 08:39 ET (13:39 GMT)","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0109394709.USD","IE00BN0W2T93.GBP","BK4533","JAZZ","BK4007","IE00BN0W2W23.USD","LU0320765992.SGD","IE00BN0W2V16.EUR","BK4532","LU0889565916.HKD","LU0823416689.USD"],"gpt_icon":0},{"id":"2585746967","title":"Jazz Pharmaceuticals downgraded to Neutral from Buy at UBS","url":"https://stock-news.laohu8.com/highlight/detail?id=2585746967","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2585746967?lang=en_us&edition=fundamental","pubTime":"2025-11-24 19:30","pubTimestamp":1763983854,"startTime":"0","endTime":"0","summary":"UBS analyst Ashwani Verma downgraded Jazz Pharmaceuticals (JAZZ) to Neutral from Buy with a price target of $188, up from $163. Following the stron...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/jazz-pharmaceuticals-downgraded-to-neutral-from-buy-at-ubs-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/jazz-pharmaceuticals-downgraded-to-neutral-from-buy-at-ubs-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1829250122.USD","IE0034235071.USD","IE00BN0W2V16.EUR","LU0320765992.SGD","BK4534","UBS","BK4532","BK4118","BK4533","BK4588","IE00BN0W2T93.GBP","JAZZ","LU0109394709.USD","IE00BN0W2W23.USD","LU0823416689.USD","BK4007","BK4585","LU0889565916.HKD"],"gpt_icon":0},{"id":"2585466778","title":"Jazz Pharmaceuticals Plc : UBS Cuts to Neutral From Buy; Raises Target Price to $188 From $163","url":"https://stock-news.laohu8.com/highlight/detail?id=2585466778","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2585466778?lang=en_us&edition=fundamental","pubTime":"2025-11-24 19:26","pubTimestamp":1763983597,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251124:nFWN3X008F:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","BK4532","LU0109394709.USD","IE00BN0W2V16.EUR","LU0320765992.SGD","IE00BN0W2W23.USD","LU0823416689.USD","LU0889565916.HKD","JAZZ","IE00BN0W2T93.GBP","BK4533"],"gpt_icon":0},{"id":"2585170056","title":"A Look at Jazz Pharmaceuticals's Valuation After Landmark HERIZON-GEA-01 Ziihera Trial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2585170056","media":"Simply Wall St.","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2585170056?lang=en_us&edition=fundamental","pubTime":"2025-11-23 00:23","pubTimestamp":1763828595,"startTime":"0","endTime":"0","summary":"Jazz Pharmaceuticals (JAZZ) released results from its Phase 3 HERIZON-GEA-01 trial, showing Ziihera combinations led to marked improvements in survival measures compared to standard therapy in advanced HER2-positive gastroesophageal cancers.\nSee our latest analysis for Jazz Pharmaceuticals.\nJazz Pharmaceuticals’ shares have been on a tear lately, with a 25% jump over the past week alone as investors responded enthusiastically to the latest clinical trial update. Momentum has steadily built...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-jazz/jazz-pharmaceuticals/news/a-look-at-jazz-pharmaceuticalss-valuation-after-landmark-her","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-jazz/jazz-pharmaceuticals/news/a-look-at-jazz-pharmaceuticalss-valuation-after-landmark-her","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LU0823416689.USD","LU0109394709.USD","LU0889565916.HKD","BK4532","IE00BN0W2V16.EUR","LU0320765992.SGD","BK4533","BK4007","IE00BN0W2T93.GBP","JAZZ","BK4211","IE00BN0W2W23.USD","LARK"],"gpt_icon":0}],"pageSize":20,"totalPage":8,"pageCount":4,"totalSize":150,"code":"91000000","status":"200"}]}}